macéra gemmothérapiesynergiearticulation
Food supplement declared in France, decision dated 19 November 2025
macéra gemmothérapiesynergiearticulation, from amélie Grange, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vitis vinifera 0.0125 mg per day, Betula pendula 0.0125 mg per day, Fraxinus excelsior 0.0125 mg per day, Ribes nigrum 0.0125 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- amélie Grange
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 1 ml
- Directions for use
- 5 à 20 gouttes par jour , en 1 à 3 prises, dans un fond de verre d 'eau en dehors des repas
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Breastfeeding women, Young children (aged 1 to 3), Pregnant women
Declaration 346512, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vitis vinifera L. | Feuille (bourgeon) | Macérât hydroglycériné | 0.0125 mg |
| Betula pendula Roth | Bourgeon | Macérât hydroglycériné | 0.0125 mg |
| Fraxinus excelsior L. | Bourgeon | Macérât hydroglycériné | 0.0125 mg |
| Ribes nigrum L. | Bourgeon | Macérât hydroglycériné | 0.0125 mg |
Additives
E422
Other ingredients
Alcool, eau
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ne pas utiliser sans avis médical . Déconseillé aux enfants en bas âge, aux femmes enceintes et allaitantes. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. Ne peut pas se substituer à une alimentation équilibrée. Agiter avant emploi.
Regulatory points
- Conditions légales
Betula pendula Roth: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Betula pendula Roth
Read the warning, when it applies and the studies cited
Birch
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).
Sources cited by Health Canada (4)
- Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “macéra gemmothérapiesynergiearticulation: composition and regulation”, https://compoatlas.com/en/supplements/products/346512-macera-gemmotherapiesynergiearticulation, updated 15 November 2026.